Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZW) EBITDA Margin (2021 - 2025)

Core Scientific (CORZW) has disclosed EBITDA Margin for 5 consecutive years, with 147.28% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin fell 7839.0% to 147.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 76.98% through Dec 2025, down 4916.0% year-over-year, with the annual reading at 76.98% for FY2025, 4916.0% down from the prior year.
  • EBITDA Margin hit 147.28% in Q4 2025 for Core Scientific, down from 67.56% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 33.85% in Q4 2021 to a low of 637.54% in Q2 2022.
  • Historically, EBITDA Margin has averaged 89.73% across 5 years, with a median of 23.65% in 2025.
  • Biggest five-year swings in EBITDA Margin: crashed -65816bps in 2022 and later soared 64500bps in 2023.
  • Year by year, EBITDA Margin stood at 33.85% in 2021, then crashed by -1650bps to 524.6% in 2022, then surged by 101bps to 2.77% in 2023, then crashed by -2585bps to 68.89% in 2024, then tumbled by -114bps to 147.28% in 2025.
  • Business Quant data shows EBITDA Margin for CORZW at 147.28% in Q4 2025, 67.56% in Q3 2025, and 33.43% in Q2 2025.